ARTES Biotechnology GmbH, Germany, and Minapharm Pharmaceuticals and Chemical Industries S.A.E., Egypt, jointly announced today the formation of a new strategic business pact, offering packet solution for biopharmaceutical processes . Aim of this new strategic business cooperation is to jointly out-license combinations of ARTES’ and Minapharm’s respective proprietary technologies and products to third parties […]
ARTES Biotechnology explored very effective in a SME consortium vaccine developments for veterinary applications. Under the titel: “ERA-Net EuroTransBio-8: PLURIVAX, development of a virus-like-particle (VLP) based vaccine platform and stable formulation especially suited for the veterinary applications, the EU cooperation was part of the 8th EuroTransBio call and was funded in the time period from […]
Meet us at the Bio-Europe Spring 2018 taking place in Amsterdam March 12 -14. Michael Piontek, Managing Director at ARTES, will be present in the One-on-One Partnering presenting ARTES’ innovative range of cell line and process development solutions for bio-pharmaceutical and vaccine products. Contact us previously for organizing a personal meeting or drop us a […]
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
ARTES and Minapharm joint forces
ARTES Biotechnology GmbH, Germany, and Minapharm Pharmaceuticals and Chemical Industries S.A.E., Egypt, jointly announced today the formation of a new strategic business pact, offering packet solution for biopharmaceutical processes . Aim of this new strategic business cooperation is to jointly out-license combinations of ARTES’ and Minapharm’s respective proprietary technologies and products to third parties […]
ARTES successfully completed EU funded project Plurivax
ARTES Biotechnology explored very effective in a SME consortium vaccine developments for veterinary applications. Under the titel: “ERA-Net EuroTransBio-8: PLURIVAX, development of a virus-like-particle (VLP) based vaccine platform and stable formulation especially suited for the veterinary applications, the EU cooperation was part of the 8th EuroTransBio call and was funded in the time period from […]
ARTES attends Bio-Europe Spring 2018
Meet us at the Bio-Europe Spring 2018 taking place in Amsterdam March 12 -14. Michael Piontek, Managing Director at ARTES, will be present in the One-on-One Partnering presenting ARTES’ innovative range of cell line and process development solutions for bio-pharmaceutical and vaccine products. Contact us previously for organizing a personal meeting or drop us a […]